Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-011524
Filing Date
2005-03-16
Accepted
2005-03-16 16:54:13
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-4618_110k.htm 10-K 1222550
2 EX-23.1 a05-4618_1ex23d1.htm EX-23.1 2644
3 EX-31.1 a05-4618_1ex31d1.htm EX-31.1 6911
4 EX-31.2 a05-4618_1ex31d2.htm EX-31.2 6927
5 EX-32.1 a05-4618_1ex32d1.htm EX-32.1 3738
6 EX-32.2 a05-4618_1ex32d2.htm EX-32.2 3742
  Complete submission text file 0001104659-05-011524.txt   1248661
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 05686148
SIC: 2836 Biological Products, (No Diagnostic Substances)